BRIEF published on 06/17/2024 at 07:05, 2 years 4 months ago Innate Pharma reveals promising results for SAR443579/IPH6101 in blood cancers Sanofi Innate Pharma SAR443579 Leukemia Blood Cancer
PRESS RELEASE published on 06/17/2024 at 07:00, 2 years 4 months ago Informations privilégiées / Autres communiqués Innate Pharma présente de nouveaux résultats sur l'essai de phase 1/2 mené par Sanofi évaluant le NK Cell Engager SAR443579/IPH6101 dans divers cancers du sang lors du congrès annuel de l'EHA 2024 Étude De Phase 1/2 Innate Pharma NK Cell Engager SAR443579/IPH6101 Cancers Du Sang
PRESS RELEASE published on 06/17/2024 at 07:00, 2 years 4 months ago Inside Information / Other news releases Innate Pharma shares updated results from the Sanofi developed blood cancer Phase 1/2 SAR443579/IPH6101 trial, showing promising clinical efficacy and safety in patients with R/R AML Sanofi Innate Pharma Blood Cancer NK Cell Engager Phase 1/2 Trial
BRIEF published on 05/28/2024 at 07:05, 2 years 5 months ago Innate Pharma annonce sa participation à de prochaines conférences investisseurs Immunothérapie Santé Conférences Investisseurs Innate Pharma Biotechnologies
BRIEF published on 05/28/2024 at 07:05, 2 years 5 months ago Innate Pharma announces its participation in upcoming investor conferences Biotechnology Investor Conferences Immunotherapy Health Innate Pharma
PRESS RELEASE published on 05/28/2024 at 07:00, 2 years 5 months ago Informations privilégiées / Autres communiqués Innate Pharma annonce sa participation à des conférences investisseurs mondiales à venir. Détails des conférences et objectif de la société biotechnologique axée sur les immunothérapies contre le cancer Biotechnologie Immunothérapie Cancer Conférences Investisseurs Innate Pharma
BRIEF published on 05/23/2024 at 22:05, 2 years 5 months ago Résultats de l'Assemblée Générale Mixte d'Innate Pharma Assemblée Générale Conseil De Surveillance Innate Pharma Résultats De Vote
BRIEF published on 05/23/2024 at 22:05, 2 years 5 months ago Results of the Combined General Meeting of Innate Pharma Voting Results Supervisory Board General Assembly Innate Pharma
PRESS RELEASE published on 05/23/2024 at 22:00, 2 years 5 months ago Informations privilégiées / Autres communiqués Innate Pharma annonce les résultats de l'Assemblée générale mixte du 23 mai 2024 avec réélection des membres du Conseil de Surveillance. Détails disponibles en ligne Résultats Conseil De Surveillance Assemblée Générale Mixte Innate Pharma Biotechnologies
PRESS RELEASE published on 05/23/2024 at 22:00, 2 years 5 months ago Inside Information / Other news releases Innate Pharma announces the voting results of its 2024 AGM. Quorum at 44.92%. Re-election of two Supervisory Board members. Details available on company's website Voting Results Supervisory Board Quorum 2024 AGM Innate Pharma
Published on 10/28/2026 at 11:00, 41 minutes ago Banyan Extends Mineralization into the Airstrip–Powerline Gap at AurMac, Yukon, Intersects 1.34 g/t Au over 20.2 metres and 1.18 g/t Au over 27.5 metres
Published on 10/28/2026 at 08:00, 3 hours 41 minutes ago Algo Grande Copper Makes New Skarn Discovery at Adelita; Step-Out Hole AG-CG-PH2-003 Returns a Combined 139.81 Metres of 1.3% CuEq from Cerro Grande and the New Margarita Skarn
Published on 10/28/2026 at 02:55, 8 hours 46 minutes ago Challenger Underground MRE Doubles to 230koz @ 3.65 g/t Au
Published on 10/28/2026 at 02:50, 8 hours 51 minutes ago Letter to Shareholders Regarding Annual General Meeting
Published on 10/27/2026 at 23:40, 12 hours 1 minute ago Second Closing of US$3.4 Million Private Placement
Published on 10/28/2026 at 11:34, 7 minutes ago Logwin reports strong first nine-month results and updates outlook for 2026
Published on 10/28/2026 at 11:29, 12 minutes ago UNAUDITED RESULTS FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2026
Published on 10/28/2026 at 11:06, 35 minutes ago You can only move fast if you know where you're going…
Published on 10/28/2026 at 11:05, 36 minutes ago New DJI Power Auro 2000 Elite Packs Car Charging and Solar Benefits Into DJI's Most Compact 2kWh Power Station
Published on 10/28/2026 at 08:00, 3 hours 41 minutes ago Edenred successfully raises €800 million in a dual-tranche bond offering
Published on 10/28/2026 at 08:00, 3 hours 41 minutes ago Edenred lève avec succès 800 millions d’euros dans le cadre d’une émission obligataire à deux tranches
Published on 10/27/2026 at 18:00, 17 hours 41 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 22, 2026
Published on 10/27/2026 at 18:00, 17 hours 41 minutes ago Nombre total de droits de vote et actions composant le capital social au 22 octobre 2026
